Lyrica (pregabalin) is a medication used to treat various conditions such as neuropathic pain, fibromyalgia, and epilepsy. According to Drug Patent Watch [1], Lyrica is available in capsules ranging from 25mg to 300mg. The recommended starting dose for most patients is 75mg twice a day, which can be increased to 150mg twice a day within one week based on individual response and tolerability. However, the dose may be adjusted based on the patient's age, weight, and medical condition.

A study published in the US National Library of Medicine [2] reported that the optimal dose of Lyrica varies depending on the patient's condition and response to treatment. The study found that some patients with neuropathic pain may benefit from lower doses of Lyrica, such as 25mg or 50mg twice a day. However, the authors suggest that patients should be monitored closely for adverse effects and efficacy.

Medscape [3] notes that Lyrica is also available in an extended-release formulation (Lyrica CR), which is taken once daily. Lyrica CR is available in doses ranging from 82.5mg to 330mg. The recommended starting dose is 82.5mg once daily, which can be increased to 165mg once daily after one week based on individual response and tolerability.

In conclusion, Lyrica can be prescribed in smaller doses such as 25mg or 50mg twice a day, depending on the patient's condition and response to treatment. However, the dose should be adjusted carefully based on the patient's age, weight, and medical condition, and patients should be monitored closely for adverse effects and efficacy.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LYRICA
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532525/
[3] https://reference.medscape.com/drug/lyrica-cr-pregabalin-343368